• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期服用vigabatrin药物患者的多焦视网膜电图和全视野视网膜电图

Multifocal ERG and full-field ERG in patients on long-term vigabatrin medication.

作者信息

Ponjavic V, Andréasson S

机构信息

Department of Ophthalmology, University of Lund, Sweden.

出版信息

Doc Ophthalmol. 2001 Jan;102(1):63-72. doi: 10.1023/a:1017589301855.

DOI:10.1023/a:1017589301855
PMID:11475366
Abstract

PURPOSE

To examine the retinal function with different electrophysiological methods in twelve Swedish patients on long-term treatment (2-10 years) with the anti-epileptic drug vigabatrin.

METHODS

Ophthalmological examination of twelve consecutive patients included testing of visual acuity, fundus inspection and fundus photography, kinetic perimetry, full-field ERG and multifocal ERG.

RESULTS

All patients had a visual acuity of 0.7 or better. Fundus inspection revealed no pathology except in one patient who had a pallor of the optic disc. All patients had a normal appearance of the macula. The result of kinetic perimetry was normal in five patients while seven patients had a concentric defect of the visual field. The 30 Hz flicker cone b-wave amplitude in the full-field ERG was abnormal in all of the seven patients with a visual field defect. None of the patients with normal visual fields had a reduction of the 30 Hz flicker cone b-wave amplitude. Six of the twelve patients had a reduced multifocal ERG response but without any correlation with visual field defect.

CONCLUSION

Long-term treatment with vigabatrin seems to selectively reduce retinal cone function. The visual field defects in patients taking vigabatrin correlate with pathology in the full-field ERG (reduction of the cone b-wave amplitude). The results from this study indicate that electroretinography can be used for monitoring patients taking vigabatrin in a more objective manner than with visual field testing.

摘要

目的

采用不同的电生理方法检查12例长期(2 - 10年)服用抗癫痫药物氨己烯酸的瑞典患者的视网膜功能。

方法

对12例连续患者进行眼科检查,包括视力测试、眼底检查和眼底摄影、动态视野检查、全视野视网膜电图(ERG)和多焦ERG。

结果

所有患者视力均为0.7或更好。眼底检查除1例视盘苍白的患者外未发现病变。所有患者黄斑外观正常。5例患者动态视野检查结果正常,7例患者有同心性视野缺损。在7例有视野缺损的患者中,全视野ERG中30Hz闪烁视锥细胞b波振幅均异常。视野正常的患者中,无一例30Hz闪烁视锥细胞b波振幅降低。12例患者中有6例多焦ERG反应降低,但与视野缺损无任何相关性。

结论

长期服用氨己烯酸似乎会选择性降低视网膜视锥细胞功能。服用氨己烯酸患者的视野缺损与全视野ERG中的病变相关(视锥细胞b波振幅降低)。本研究结果表明,视网膜电图可用于比视野测试更客观地监测服用氨己烯酸的患者。

相似文献

1
Multifocal ERG and full-field ERG in patients on long-term vigabatrin medication.长期服用vigabatrin药物患者的多焦视网膜电图和全视野视网膜电图
Doc Ophthalmol. 2001 Jan;102(1):63-72. doi: 10.1023/a:1017589301855.
2
Attenuation of the retinal nerve fibre layer and reduced retinal function assessed by optical coherence tomography and full-field electroretinography in patients exposed to vigabatrin medication.使用光学相干断层扫描和全视野视网膜电图评估暴露于氨己烯酸药物的患者的视网膜神经纤维层衰减和视网膜功能降低。
Acta Ophthalmol. 2014 Mar;92(2):149-57. doi: 10.1111/aos.12030. Epub 2013 Feb 7.
3
Electroretinographic (ERG) responses in pediatric patients using vigabatrin.使用vigabatrin的儿科患者的视网膜电图(ERG)反应。
Doc Ophthalmol. 2012 Jun;124(3):197-209. doi: 10.1007/s10633-012-9320-7. Epub 2012 Mar 20.
4
Changes in the ERG d-wave with vigabatrin treatment in a pediatric cohort.在一个儿科队列中,加巴喷丁治疗对视网膜电图d波的影响。
Doc Ophthalmol. 2014 Oct;129(2):97-104. doi: 10.1007/s10633-014-9453-y. Epub 2014 Jul 10.
5
Visual field and electrophysiological abnormalities due to vigabatrin.由于氨己烯酸导致的视野和电生理异常。
Doc Ophthalmol. 2002 Mar;104(2):181-8. doi: 10.1023/a:1014615517996.
6
Full-field ERG and visual fields in patients 5 years after discontinuing vigabatrin therapy.停用氨己烯酸治疗5年后患者的全视野视网膜电图和视野检查
Doc Ophthalmol. 2008 Sep;117(2):93-101. doi: 10.1007/s10633-007-9108-3. Epub 2008 Jan 10.
7
Electro-oculography, electroretinography, visual evoked potentials, and multifocal electroretinography in patients with vigabatrin-attributed visual field constriction.丙戊酸引起的视野缩窄患者的眼电图、视网膜电图、视觉诱发电位和多焦视网膜电图
Epilepsia. 2000 Nov;41(11):1420-31. doi: 10.1111/j.1528-1157.2000.tb00117.x.
8
Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings.与氨己烯酸相关的视网膜锥系统功能障碍:视网膜电图和眼科检查结果
Neurology. 1998 Mar;50(3):614-8. doi: 10.1212/wnl.50.3.614.
9
Retinal function abnormalities in patients treated with vigabatrin.
Arch Ophthalmol. 2003 Jun;121(6):811-6. doi: 10.1001/archopht.121.6.811.
10
Symptomatic and asymptomatic visual loss in patients taking vigabatrin.服用vigabatrin的患者出现的有症状和无症状视力丧失。
Ophthalmology. 1999 Sep;106(9):1792-8. doi: 10.1016/S0161-6420(99)90345-7.

引用本文的文献

1
Correlation Between Fixed-Luminance Flicker Full-Field Electroretinogram Response and Macular Cone Density in Healthy Individuals.健康个体中固定亮度闪烁全视野视网膜电图反应与黄斑区视锥细胞密度的相关性
Life (Basel). 2025 Apr 24;15(5):694. doi: 10.3390/life15050694.
2
Effects of medications on the human electroretinogram: A comprehensive review.药物对人体视网膜电图的影响:一项全面综述。
Surv Ophthalmol. 2025 Apr 12. doi: 10.1016/j.survophthal.2025.04.003.
3
Evaluation of correlation between Diopsys® NOVA™ fixed-luminance flicker ERG and Diagnosys® Espion 2™ flicker ERG parameters.

本文引用的文献

1
Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy.接受vigabatrin或卡马西平单药治疗的癫痫患者的色觉
Ophthalmology. 2000 May;107(5):884-8. doi: 10.1016/s0161-6420(00)00077-4.
2
Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings.接受vigabatrin治疗患者的视觉功能障碍:临床及电生理检查结果
Neurology. 1999 Dec 10;53(9):2082-7. doi: 10.1212/wnl.53.9.2082.
3
Visual field defects associated with vigabatrin therapy.与vigabatrin治疗相关的视野缺损。
评价 Diopsys® NOVA™ 固定亮度闪烁视网膜电图与 Diagnosys® Espion 2™ 闪烁视网膜电图参数之间的相关性。
Doc Ophthalmol. 2023 Jun;146(3):257-266. doi: 10.1007/s10633-023-09934-x. Epub 2023 May 23.
4
Therapeutic effect of the mesenchymal stem cells on vigabatrin-induced retinopathy in adult male albino rat.间充质干细胞对成年雄性白化大鼠中 vigabatrin 诱导的视网膜病变的治疗作用。
Anat Cell Biol. 2022 Jun 30;55(2):217-228. doi: 10.5115/acb.22.006.
5
OV329, a novel highly potent γ-aminobutyric acid aminotransferase inactivator, induces pronounced anticonvulsant effects in the pentylenetetrazole seizure threshold test and in amygdala-kindled rats.OV329,一种新型高效γ-氨基丁酸氨基转移酶失活剂,在戊四氮惊厥阈试验和杏仁核点燃大鼠中诱导明显的抗惊厥作用。
Epilepsia. 2021 Dec;62(12):3091-3104. doi: 10.1111/epi.17090. Epub 2021 Oct 7.
6
Retinal defect in children with infantile spasms of varying etiologies: An observational study.不同病因婴儿痉挛症患儿的视网膜病变:一项观察性研究。
Neurology. 2020 Feb 11;94(6):e575-e582. doi: 10.1212/WNL.0000000000008686. Epub 2019 Dec 2.
7
Electrophysiological assessment for early detection of retinal dysfunction in β-thalassemia major patients.用于早期检测重型β地中海贫血患者视网膜功能障碍的电生理评估
Graefes Arch Clin Exp Ophthalmol. 2017 Jul;255(7):1349-1358. doi: 10.1007/s00417-017-3650-9. Epub 2017 Mar 30.
8
Evaluation of cone function by a handheld non-mydriatic flicker electroretinogram device.使用手持式非散瞳闪烁视网膜电图设备评估视锥细胞功能。
Clin Ophthalmol. 2016 Jun 30;10:1175-85. doi: 10.2147/OPTH.S104721. eCollection 2016.
9
Vigabatrin retinal toxicity in children with infantile spasms: An observational cohort study.婴儿痉挛症儿童中氨己烯酸的视网膜毒性:一项观察性队列研究。
Neurology. 2014 Dec 9;83(24):2262-8. doi: 10.1212/WNL.0000000000001069. Epub 2014 Nov 7.
10
(1S, 3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a potent γ-aminobutyric acid aminotransferase inactivator for the treatment of cocaine addiction.(1S, 3S)-3-氨基-4-二氟亚甲基-1-环戊烷羧酸(CPP-115),一种用于治疗可卡因成瘾的强效γ-氨基丁酸转氨酶失活剂。
J Med Chem. 2012 Jan 12;55(1):357-66. doi: 10.1021/jm201231w. Epub 2011 Dec 30.
J Neurol Neurosurg Psychiatry. 1999 Dec;67(6):716-22. doi: 10.1136/jnnp.67.6.716.
4
Symptomatic and asymptomatic visual loss in patients taking vigabatrin.服用vigabatrin的患者出现的有症状和无症状视力丧失。
Ophthalmology. 1999 Sep;106(9):1792-8. doi: 10.1016/S0161-6420(99)90345-7.
5
Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin.与vigabatrin相关的周边视野收缩患者的电生理评估。
Arch Ophthalmol. 1998 Jun;116(6):817-9.
6
Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings.与氨己烯酸相关的视网膜锥系统功能障碍:视网膜电图和眼科检查结果
Neurology. 1998 Mar;50(3):614-8. doi: 10.1212/wnl.50.3.614.
7
Severe persistent visual field constriction associated with vigabatrin. Asymptomatic as well as symptomatic defects occur with vigabatrin.与氨己烯酸相关的严重持续性视野缩窄。氨己烯酸可导致无症状以及有症状的视野缺损。
BMJ. 1998 Jan 17;316(7126):233.
8
The influence of established and new antiepileptic drugs on visual perception. 1. A placebo-controlled, double-blind, single-dose study in healthy volunteers.
Epilepsy Res. 1997 Dec;29(1):35-47. doi: 10.1016/s0920-1211(97)00060-0.
9
Phenotypes in three Swedish families with X-linked retinitis pigmentosa caused by different mutations in the RPGR gene.三个瑞典家庭中由RPGR基因不同突变引起的X连锁视网膜色素变性的表型。
Am J Ophthalmol. 1997 Jul;124(1):95-102. doi: 10.1016/s0002-9394(14)71649-6.
10
Severe persistent visual field constriction associated with vigabatrin. Manufacturers have started several studies.与vigabatrin相关的严重持续性视野缩窄。制造商已开展多项研究。
BMJ. 1997 Jun 7;314(7095):1694-5.